|
CRON | Cronos Group Inc. |
|
|
CRON | Cronos Group Inc. |
| Medicinal Chemicals & Botanical Products |
| Book value per $ invested | $ 3.25 |
| Leverage | 4.39% |
| Market Cap | $ 1.0B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -1.8m |
| Margin | -1.13% |
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.